Financhill
Back

Surmodics 10K Form

Sell
27

SRDX
Surmodics

Last Price:
29.23
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive SRDX News And Ratings

See the #1 stock for the next 7 days that we like better than SRDX

SRDX Financial Statistics

Sales & Book Value

Annual Sales: $132.58M
Cash Flow: $-9.51M
Price / Cash Flow: 41.22
Annual Sales: $8.58
Price / Book: 3.37

Profitability

EPS (TTM): 0.38000
Net Income (TTM): $5.52M
Gross Margin: $61.02M
Return on Equity: 4.89%
Return on Assets: 3.1%

Surmodics Earnings Forecast

Key Surmodics Financial Ratios

  • The Gross Profit Margin over the past 26 years for SRDX is 46.03%.
  • The Selling, General & Administrative Expenses for SRDX have been equal to 39.13% of Gross Profit Margin.
  • The Research & Development expenses have been 52.91% of Revenue.
  • The Interest Expense is -227.15% of Operating Income.
  • The Net Earning history of SRDX is -1.16% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Surmodics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sector: Healthcare
Current Symbol: SRDX
CUSIP: 868873
Website: surmodics.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 4.84
Quick Ratio: 3.75

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SRDX Technical Analysis vs Fundamental Analysis

Sell
27
Surmodics (SRDX) is a Sell

Is Surmodics a Buy or a Sell?

  • Surmodics stock is rated a Sell
    The current Surmodics [SRDX] share price is $28.90. The Score for SRDX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.